Kinetochores are large protein-based structures that assemble on centromeres during cell division and link chromosomes to spindle microtubules. Proper distribution of the genetic material requires that sister kinetochores on every chromosome become bioriented by attaching to microtubules from opposite spindle poles before progressing into anaphase. However, erroneous, non-bioriented attachment states are common and cellular pathways exist to both detect and correct such attachments during cell division. The process by which improper kinetochore-microtubule interactions are destabilized is referred to as error correction. To study error correction in living cells, incorrect attachments are purposely generated via chemical inhibition of kinesin-5 motor, which leads to monopolar spindle assembly, and the transition from mal-orientation to biorientation is observed following drug washout. The large number of chromosomes in many model tissue culture cell types poses a challenge in observing individual error correction events. Drosophila S2 cells are better subjects for such studies as they possess as few as 4 pairs of chromosomes. However, small molecule kinesin-5 inhibitors are ineffective against Drosophila kinesin-5 (Klp61F). Here we describe how to build a Drosophila cell line that effectively replaces Klp61F with human kinesin-5, which renders the cells sensitive to pharmacological inhibition of the motor and suitable for use in the cell-based error correction assay.
Introduction
Equal segregation of the genome during cell division requires correct interactions between the replicated DNA and spindle microtubules. Microtubules physically interact with chromosomes through an ensemble of proteins that assembles at centromeres known as the kinetochore 1 . Correct distribution of the chromosomes requires that sister kinetochores are bioriented, in which each sister is associated with microtubules originating from opposite spindle poles. Kinetochore microtubule (kt-MT) attachments that are not in the bioriented conformation are quickly and efficiently destabilized to provide the opportunity to establish biorientation in a process known as error correction. An error correction assay that was previously established in mammalian cells 5 requires assembling monopolar spindles using reversible small molecule inhibitors against Eg5 (kinesin-5). The drug treatment generates a multitude of erroneous syntelic attachments in which both sister kinetochores attach to the same spindle pole. A subsequent washout of the drug allows for visualization of the error correction process. The error correction assay can be done in the presence of small molecule inhibitors or knockdowns to study the contribution of candidate proteins to correcting erroneous kt-MT attachments.
The ability to visualize error correction in living cells is a powerful tool to further understand the molecular mechanism involved in this complex process. However, the large number of chromosomes present in most cell lines poses a challenge in observing individual kt-MT attachments. Drosophila S2 cells would be ideal for applying the error correction assay as they contain as few as 4 chromosomes 6 , but small molecule inhibitors of kinesin 5 such as S-trityl-L-cysteine (STLC) and monastrol [7] [8] [9] do not affect spindle assembly or kinesin-5 motor function in Drosophila cells. We therefore generated a Drosophila S2 cell line expressing human kinesin-5 under an inducible promoter that is sensitive to kinesin-5 inhibitors. This protocol describes how to knockdown the endogenous Drosophila kinesin-5 homologue, Klp61F, and use this cell line in the cellbased error correction assay. To make concanavalin A-coated coverslips, pipette enough volume of concanavalin A solution (0.5 mg/ml dissolved in H 2 O) to coat an acid washed coverslip, remove the excess, and allow the coverslip to air dry. 6. Place a 22 mm x 22 mm concanavalin A-coated coverslip in a clean 35 mm tissue culture dish, then seed 500 µl at 100% confluency of the induced cells onto the coverslip and allow the cells to adhere for 1 hr at RT. 7. To check for Eg5-mCherry expression, assemble the coverslip into a rose chamber (or appropriate imaging vessel) with media for imaging at RT on a fluorescence microscope. Use appropriate light sources and filter sets to visualize the cells. For example, the microscope used in this study has an LED white light source and EGFP (FITC/Cy2) and DSRed (TRITC/Cy3) filter cubes. Eg5-mCherry localizes to microtubules and is enriched near spindle poles. 8. After ensuring that the cells are expressing both Eg5-mCherry and GFP-α-tubulin, transfer the remainder of the transfected, uninduced cells to a 25 cm 2 tissue culture flask containing 4 ml of Schneider's media. Note: Here, the fixation protocol can be stopped to be continued at a later point. Coverslips can be stored in a moisture chamber at 4°C for up to 24 hr. To make the moisture chamber, line the rim of a 150 mm dish with a wet laboratory wipe and cover with the Petri dish lid. 7. Remove block, and incubate the coverslips for 1 hr at RT with 150 µl of primary antibodies diluted appropriately in BDS to stain for kinetochores and microtubules to final concentrations of 2 µg/ml (or according to manufacturer's recommendations) and 1 µg/ml, respectively. Note: Here, the fixation protocol can be stopped to be continued at a later point. Coverslips can be stored in a moisture chamber at 4°C for up to 24 hr. 8. Wash coverslips 3x with 500 µl of 1x PBS + 0.1% Triton-X. 9. Incubate coverslips for 30-60 min at RT with the appropriate fluorophore-conjugated secondary antibodies diluted in BDS. 10. Wash coverslips 3x with 500 µl of 1x PBS + 0.1% Triton-X. 11. Incubate coverslips with 150 µl of BDS containing 1 µg/ml DAPI final concentration for 5 min. 12. Wash coverslips 2x with 1x PBS + 0.1% Triton-X, and mount coverslips cell side down on a 3x1" slide with 8 µl of mounting media.
Paint the corners with nail polish to immobilize the coverslips onto slides.
9. Image cells with bipolar spindles that are expressing Eg5-mCherry. Take a Z series consisting of 30 planes at 0.2 µm intervals in all channels using a 100X objective. Carefully analyze the kinetochores and microtubules to determine the attachment states (bioriented or syntelic attachments).
Representative Results
Klp61F is required to form bipolar spindles. The human kinesin-5, Eg5, can rescue the function of Klp61F in Drosophila S2 cells (Figure 1A and D). Upon addition of the kinesin-5 inhibitor (STLC), microtubule-associated levels of the motor drop ( Figure 1B and E) , and the spindle collapses, resulting in a monopole ( Figure 1C and F) in cells lacking endogenous Klp61F upon successful RNAi (Supplemental movie 1). It is noteworthy that bipolar spindles collapse upon addition of STLC in the humanized S2 cells because kinesin-5 activity is not required to maintain spindle bipolarity in human cells. This interesting discrepancy may be a result of differences in interpolar microtubule overlap and/or stability in the two model systems 14 . Kinesin-5 inhibition (Figure 2A and E) can be reversed by washing out the drug and recovery of a bipolar spindle can be followed over time. Upon removal of the inhibitor (Figure 2B and F) , Eg5-mCherry re-associates with the microtubules as a bipolar spindle assembles ( Figure 2C and G) , and cells can progress into a bipolar anaphase ( Figure 2D and H, Supplemental movie 2). Although Drosophila S2 cells can be a better cell line to study error correction, the multiple steps involved in obtaining the cell line and knocking down essential genes poses some challenges to this technique. For instance, transfection efficiency can be quite low. If less than 20% of the cells are expressing the Eg5-mCherry, the transfection should be repeated as the selection process will take longer. Also, the percentage of cells expressing both fluorescent proteins may decrease over time. This can be overcome by splitting cells in the presence of Blasticidin S HCl and Hygromycin B to select for cells expressing Eg5-mCherry and GFP-α-tubulin, respectively. It is also important to note that Drosophila S2 cells have orthologues to many human proteins and; therefore, it is critical to optimize the knockdown conditions for the endogenous proteins. Optimal knockdown conditions may vary in the amount of dsRNA and the length of treatment. Considering the emergence and rapid improvement of CRISPR-Cas9 technologies [15] [16] [17] , generation of a Drosophila cell line with the Klp61F gene replaced by human Eg5 presents a powerful alternative that would overcome the limitations of the transfection and knockdown approach. Our work demonstrates that fly-to-human gene replacement should be a viable option in this case although the necessary reagents to do so in Drosophila S2 cells are currently being developed.
This procedure is not limited to Eg5, but can be applied to study the function of other proteins of interest. If using inhibitors that have previously been established to be ineffective in Drosophila S2 cells, this protocol can be modified to study the direct effect of inhibitors in live cells without concerns about off target effects. The cell line produced using this protocol could also be used in high-throughput screening analyses to identify potential drugs targeting proteins involved in error correction.
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